MedCap AB (FRA:61MA) ROCE % : 14.55% (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is MedCap AB ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. MedCap AB's annualized ROCE % for the quarter that ended in Dec. 2024 was 14.55%.

MedCap AB ROCE % Historical Data

The historical data trend for MedCap AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedCap AB ROCE % Chart

MedCap AB Annual Data

Trend

Apr15

Apr16

Apr17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

13.49

14.39

15.89

19.29

18.60

MedCap AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial															26.10	22.21	21.37	17.84	14.55

MedCap AB ROCE % Calculation

MedCap AB's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	24.394	/	( ( (148.596 - 30.672)	+	(173.126 - 28.811) )	/ 2 )
	=	24.394	/	( (117.924	+	144.315)	/ 2 )
	=	24.394	/	131.1195
	=	18.60 %

MedCap AB's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	20.516	/	( ( (166.838 - 29.235)	+	(173.126 - 28.811) )	/ 2 )
	=	20.516	/	( ( 137.603	+	144.315 )	/ 2 )
	=	20.516	/	140.959
	=	14.55 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

MedCap AB (FRA:61MA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

MedCap AB ROCE % Related Terms

Thank you for viewing the detailed overview of MedCap AB's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

MedCap AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MedCap AB (FRA:61MA) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

MCAP:Sweden MCAPs:UK

Address

Sundbybergsvagen 1, Solna, SWE, 171 73

Website

https://www.medcap.se

MedCap AB acquires and develops profitable, market-leading niche companies in the Nordic life science industry. It is diversified into two business areas namely Medical technology and Specialist medicines. Medical Technology mainly develops and sells various medical technology products and services. Its Specialist medicines develop and sell medicines within the regulatory classes of registered, extemporaneous and licensed medicines.

MedCap AB Headlines

No Headlines